The influence of interferon-α and combination interferon-α and lamivudine therapy on height and weight in children with chronic hepatitis B infection

Journal of Pediatric Endocrinology and Metabolism

Volumn 20, Issue 5, 2007, Pages 615-620

  Kuloǧlu, Zarife ^a,b   Kansu, Aydan ^a   Demirçeken, Fulya ^a   Arici, Z Serap ^a   Berbergoǧlu, Merih ^a   Öcal, Gönül ^a   Girgin, Nurten ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b Camlitepe Mahallesi   (Turkey)

Author keywords

Children; Chronic hepatitis B; Growth; Interferon; Lamivudine

Indexed keywords

ALPHA2A INTERFERON; LAMIVUDINE;

ARTICLE; BODY HEIGHT; BODY WEIGHT; CHILD; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GROWTH RATE; HEPATITIS B; HUMAN; MALE; MONOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; WEIGHT GAIN;

EID: 34250713929     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2007.20.5.615     Document Type: Article

References (22)

1. Wai CT, Lok ASF. Treatment of hepatitis B. J Gastroenterol 2002; 37: 771-778.
2. Yuen MF, Lai CL. Treatment of chronic hepatitis B. Lancet Infect Dis 2001; 1: 232-241.
3. Tovo PA, Lazier L, Versace A. Hepatitis B virus and hepatitis C virus infections in children. Curr Opin Infect Dis 2005; 18: 261-266.
4. Broderick A, Jonas MM. Management of hepatitis B in children. Clin Liver Dis 2004; 8: 387-401.
5. Gottrand F, Michaud L, Guimber D, Ategbo S, Dubar G, Turck D, Farriaux JP. Influence of recombinant interferon alpha on nutritional status and growth pattern in children with chronic viral hepatitis. Eur J Pediatr 1996; 115: 1031-1034.
6. Comanor L, Minor J, Conjeevaram HS, Roberts EA, Alvarez F, Bern EM, Goyens P, Rosenthal P, Lachaux A, Shelton M, Sarles J, Sokal EM. Impact of chronic hepatitis B and interferon-α therapy on growth of children. J Viral Hepat 2001; 8: 139-147.
7. Shiraki K, Morishima T, Teresewa S, Koike M, Fujisawa T, Tajiri H. Long-term virologic response and growth rate of children with chronic hepatitis C who received natural interferon-α. Eur J Pediatr 2002; 161: 629-630.
8. Tanner J, Whitehouse R. Clinical longitudinal standards for height, weight, height velocity and weight velocity and stages of puberty. Arch Dis Child 1976; 51: 170-179.
9. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assesing histologic activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-438.
10. Bortolotti F, Calzia R, Vegnente A, Cadrobbi P, Rugge M, Armigliato M, Marazzi MG, Iorio R, Crivellaro C, Piscopo R, et al. Chronic hepatitis in childhood: the spectrum of the disease. Gut 1988; 29: 659-664.
11. Ruiz-Moreno M. Chronic hepatitis B infection in children. Natural history and treatment. J Hepatol 1993; 17 (Suppl 3): S64-S66.
12. Jara P, Bortolotti F. Interferon-α treatment of chronic hepatitis B in childhood: a consensus advice based on experience in European children. J Pediatr Gastroenterol Nutr 1999; 29: 163-170.
13. Broderick AL, Jonas MM. Hepatitis B in children. Semin Liver Dis 2003; 23: 59-68.
14. Bortolotti F. Treatment of chronic hepatitis B in children. J Hepatol 2003; 39 (Suppl 1): S200-205.
15. Bortolotti F, Jara P, Barbera C, Gregorio GV, Vegnente A, Zancan L, Hierro L, Crivellaro C, Vergani GM, Iorio R, Pace M, Con P, Gatta A. Long term effect of alpha interferon in children with chronic hepatitis B. Gut 2000; 46: 715-718.
16. Kansu A, Altuntaş B, Doǧanci T, Kalayci AG, Girgin N. The efficacy and side effects of interferon alpha 2a on chronic hepatitis B virus infection in Turkish children. Hepatol Res 1999; 15: 1-9.
17. Renault PF, Hoofnagle JH. Side effect of alpha interferon. Semin Liver Dis 1989; 9: 273-277.
18. Ruiz-Moreno M, Rua MJ, Molina J, Moraleda G, Moreno A, Garcia-Aguado J, Carreno V. Prospective, randomized, controlled trial of interferon-α in children with chronic hepatitis B. Hepatology 1991; 13: 1035-1039.
19. Utili R, Sagnelli E, Galanti B, Aprea L, Cesaro G, Digilio L, Filippini P, Felaco FM, Gaeta GB, Marrone A, et al. Prolonged treatment of children with chronic hepatitis B with recombinant α 2a-interferon: a controlled, randomized study. Am J Gastroenterol 1990; 86: 327-330.
20. Johnson MA, Bye JB. A study of the pharmacokinetic interaction between lamivudine and alpha interferon. Eur J Clin Pharmacol 2000; 56: 289-292.
21. Vegnente A, Guida S, Di Costanzo V, Fusco C, Iorio R, Toscano P. Nutritional status and growth in children with chronic hepatitis B. J Pediatr Gastroenterol Nutr 1992; 14: 123-127.
22. Polito C, La Manna A, Cartiglia ML, Bonomo G, Del Gado R. Normal growth of children with HBsAg positive chronic active hepatitis (CAH): Acta Paediatr Scand 1991; 80: 1231-1232.